In vivo brain microdialysis was used to characterize the daily pattern of extracellular excitatory amino acids (EAA; glutamate and aspartate), glutamine and 5-hydroxyindoleacetic acid (5-HIAA) in the region of the suprachiasmatic nucleus (SCN) in freely behaving male Syrian hamsters. Diurnal variations in the extracellular concentrations of EAA and 5-HIAA observed under 14:10-h light-dark (LD) photoperiod were confirmed by cosinor analysis. Peak levels occurred during the night, with the mean acrophasis for 5-HI-AA concentration preceding that for EAA by 1-2 h. Release of EAA was stimulated by K(+)-induced depolarization in a Ca(2+)-dependent manner and was not affected by tetrodotoxin. In the absence of light cues (constant dim red light, < 0.4 lx; DD) there was a significant time-of-day effect in peak glutamate concentration (occurring during subjective night), but the rhythmic pattern of 5-HIAA output was lost. There was no apparent direct temporal linkage between peaks in extracellular EAA or 5-HIAA and bouts of wheel-running activity under LD or DD. These results are evidence that 1) the daily release pattern of extracellular glutamate, but not 5-HIAA, is circadian in nature; and 2) this rhythm in glutamate is not based on Na+ channel-dependent action potentials. Finally, a discordance in the timing of peak nocturnal extracellular 5-HIAA and EAA concentrations was evident, possibly reflecting an interplay between serotonergic and EAA pathways in the SCN.
This study examined the effects of transfer from long photoperiod (LP) to short photoperiod (SP) on the cessation of ovarian cyclicity and the castration response in inbred LSH/SsLak golden Syrian hamsters. Forty-six 8 to 10-wk-old female hamsters were acclimatized in LP (14L:10D; lights on at 0600 h) during which time animals were monitored for regular ovarian cyclicity. Twenty-six animals were transferred to SP (8L:16D; lights on at 0600 h) and examined daily for vaginal discharges. One day after the day of the first missed ovulation, individual SP-exposed animals were bilaterally ovariectomized; concomitantly, an LP control animal in diestrus I underwent the same procedure. Thirty days after ovariectomy, the hamsters were fitted with intra-atrial silastic cannulae. On the following two postoperative days, 0.6 ml blood samples were collected at 0700, 1200, 1400, and 1600 h for SP animals and at 0700, 1400, 1600 and 1800 h for LP controls. On the third day, the animals were decapitated and sera and pituitaries saved for determination of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and prolactin (PRL) by radioimmunoassay (RIA). All SP-exposed animals displayed their last estrous discharge 14-34 days after transfer to SP (mean = 23.0 +/- 0.8 days). Their ovaries were characterized by the absence of corpora lutea, the presence of large atretic antral follicles, few growing follicles, and interstitium that was stimulated to varying degrees. Total and adjusted pituitary weights were decreased by SP exposure (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Twenty-six in-patients with Diagnostic and Statistical Manual version IV (DSM-IV) criteria for opioid dependence were selected at random to receive either a combination of an 11-day low-dose buprenorphine and a 14-day carbamazepine regimen (n = 14) or a combination of an 11-day methadone and a 14-day carbamazepine regimen (n = 12) in a double-blind, randomized 14-day in-patient detoxification treatment. Patients with buprenorphine and carbamazepine showed a significantly better psychological state after the first and second weeks of treatment. Above all, the buprenorphine-treated patients demonstrated a less marked tiredness, sensitiveness and depressive state as well as a more prominent elevated mood during the detoxification process. Seven non-completers (after 7 days: four of 12 = 33.3%; after 14 days: seven of 12 = 58.3%) were treated with methadone and carbamazepine and five non-completers (after 7 days: two of 14 = 14.3%; after 14 days: five of 14 = 35.7%) received buprenorphine and carbamazepine. The difference in the overall dropout rate after day 14 was not significant. The present study supports the hypothesis that the combination of buprenorphine and carbamazepine leads to a better clinical outcome than does a combination of methadone and carbamazepine in the detoxification of opioid addicts with additional multiple drug abuse. The buprenorphine and carbamazepine-regimen provides a more effective short-term relief of affective disturbances than does methadone and carbamazepine. No severe side effects occurred during the treatment period in both groups.
This study was designed to examine the effects of short photoperiod (SP) exposure on gonadotropin and PRL levels in the presence and absence of estrogen treatment in ovariectomized LSH/SsLak hamsters. In experiment I, regularly cycling hamsters maintained in long photoperiod (14L:10D) were ovariectomized and Silastic capsules containing 2.0-mm columns of estradiol benzoate (EB) implanted simultaneously into half of the animals. On the following day, half of the animals in each treatment group were transferred to SP (8L:16D). After 20 days of SP or long photoperiod (LP) exposure, all animals were sacrificed by decapitation and their sera and pituitaries saved for hormonal determinations. The experimental protocol in experiment II was similar, except that two groups in each photoperiod received estrogen treatments; one group received 2.0-mm implants of 17-beta-estradiol (E2), whereas a second group received 10.0-mm E2 implants. SP treatment effected a reduction in serum LH and FSH levels in the absence of steroid replacement treatment. EB treatment depressed serum gonadotropin levels in LP animals, but did not alter levels in SP hamsters. In experiment II, LP- and SP-treated animals showed similar responses to E2 treatment, although different responses were noted in the two dosage groups. Pituitary gonadotropin contents became progressively decreased with increasing steroid levels and in certain groups showed SP-induced reductions. Serum and pituitary PRL levels increased in response to steroid treatment, but were not affected by SP treatment. In summary, 20 days of SP treatment caused gonad-independent reductions in gonadotropin levels and appeared to reduce the steroid feedback sensitivity of the hypothalamo-pituitary axis. PRL levels were not affected by SP exposure in the absence of the ovaries, and the interaction of PRL and estrogen appeared to be similar in both photoperiods.
Anestrus brought about after 2-4 weeks of short photoperiod (SP) exposure in LSH/SsLak hamsters is preceded by impaired follicular development. Since the latter is critically dependent on adequate FSH levels, this study tested the hypothesis that SP might alter baseline or compensatory FSH levels prior to the onset of anestrus.Regularly cycling females in 14L:lOD (LP) were transferred to SP (8L:16D). Between 0800 and 0900 h on days 20 through 24 of SP exposure, half of the animals in diestrus I1 were unilaterally ovariectomized (UO), and the remaining animals were shamoperated (Sham-UO). Seven hours after surgery, blood samples were taken via cardiac puncture. All animals were killed the following morning at 0900 h. Uterine weights were significantly reduced in SP-exposed hamsters, yet the compensatory increase in FSH following unilateral ovariectomy was not affected; a tendency for higher levels was noted. On proestrus, serum and pituitary FSH levels of SP-exposed Sham-UO animals were significantly elevated over similarly treated LP-exposed hamsters. Interestingly, in animals with severe follicular impairment, the highest FSH levels correlated with the lowest uterine weights. The data suggest that SP exposure does not impair compensatory FSH release or the ability of the ovaries to respond to UO. SP-induced elevations in FSH levels may result from reduced follicular secretion and reduced inhibin and/or estrogen levels.
Previous experiments showed that LSH/SsLak female hamsters cease ovarian cyclicity after 2-4 weeks of short photoperiod (SP) treatment. This study was designed to reveal early hormonal and histological changes on day 1 of the estrous cycle (estrus) in SP-treated animals and changes brought about by the SP-induced acyclic condition. Groups of 8-10 animals were killed on day 1 after 0, 4, 8, 12, and 16 days of SP treatment; sera and pituitaries were saved for hormone determinations, and ovaries were prepared for histological analysis. Intraatrial cannulae were inserted into anovulatory animals, and blood samples were withdrawn on the first and second postoperative days; the animals were killed on the third postoperative day. PRL levels were significantly reduced in cycling animals after 16 days of SP exposure and diminished further in acyclic animals. Pituitary PRL did not change in cycling animals, although it was highly depressed in SP-treated acyclic animals. The estrous FSH surge, serum LH levels, and pituitary gonadotropin contents were not affected by SP in cycling animals; in anovulatory animals, pituitary gonadotropin contents were significantly increased, and daily afternoon gonadotropin surges were observed. Uterine weights were reduced in cycling animals and underwent a further reduction after cyclicity ceased. Ovarian analysis revealed that all cycling animals had the same number of recruited follicles, yet significantly fewer corpora lutea and an apparent increase in atretic antral follicles were observed after 16 days of SP exposure. These results suggest that SP-induced cessation of estrous cyclicity occurs abruptly. SP does not alter the secondary FSH surge, but might adversely affect maintenance of follicular growth and depress serum PRL levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.